Response to - Letter to the editor 'Transparietal diffusion of polidocanol: Potential complication of sclerotherapy?'

Phlebology. 2023 Dec;38(10):700. doi: 10.1177/02683555231198409. Epub 2023 Oct 11.

Authors

Mina Kang^{1

2}, Kurosh Parsi^{1

2}

Affiliations

¹ Department of Dermatology, St Vincent's Hospital, Sydney, NSW, Australia.
² Dermatology, Phlebology, Fluid Mechanics Research Laboratory, St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.

PMID: 37821217
DOI: 10.1177/02683555231198409

No abstract available

Publication types

Letter

MeSH terms

Humans
Polidocanol / adverse effects
Polyethylene Glycols* / adverse effects
Sclerotherapy* / adverse effects

Substances

Polidocanol
dodecylnonaoxyethylene glycol monoether
Polyethylene Glycols